Form 4 for VYGR Voyager Therapeutics, Inc.
Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0001104659-26-012679 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-10 | 2026-02-06 | VYGR | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +45.0K | 183.9K | +32% | $0 |
| D | 2026-02-10 | 2026-02-06 | VYGR | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +210.0K | 210.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | A | A | 45,000 | $0.00 | 183,914 | D | — | — | (F1) Consists of shares of common stock issuable under an aggregate of 45,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 6, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-06 | A | A | 210,000 | $0.00 | 210,000 | D | $3.68 · — to 2036-02-06 | 210,000 Common Stock | (F2) This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 6, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service. |